Ernst V. Arnold

Array ( [id] => 18786049 [patent_doc_number] => 20230374014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => CGAS INHIBITING TRIAZOLOPYRIMIDONE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/999194 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17065684 [patent_doc_number] => 20210267899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => MINIMIZING AGGLOMERATION OF DRUG PARTICLE COATING MATERIAL DURING STORAGE TO STABILIZE DISINTEGRATION TIMES OF PHARMACEUTICAL PRODUCTS [patent_app_type] => utility [patent_app_number] => 17/307638 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17198617 [patent_doc_number] => 20210338711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => AQUEOUS ANTI MICROBIAL COMPOSITION USEFUL AS A THERAPEUTIC MATERIAL [patent_app_type] => utility [patent_app_number] => 17/246887 [patent_app_country] => US [patent_app_date] => 2021-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17198619 [patent_doc_number] => 20210338713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => Reduction of Pulmonary Inflammation Using Therapeutic Gas Mixtures [patent_app_type] => utility [patent_app_number] => 17/306719 [patent_app_country] => US [patent_app_date] => 2021-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14092 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18769531 [patent_doc_number] => 20230364301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => METHODS FOR PREPARATION OF A TERMINALLY STERILIZED HYDROGEL OR COLLOIDAL SUSPENSION DERIVED FROM EXTRACELLULAR MATRIX, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/044969 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20527250 [patent_doc_number] => 12545674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-10 [patent_title] => Crystal of trifluoromethyl/chloro disubstituted sulfonamide selective BCL-2 inhibitor [patent_app_type] => utility [patent_app_number] => 17/922223 [patent_app_country] => US [patent_app_date] => 2021-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 10002 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18535901 [patent_doc_number] => 20230240987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHODS OF TREATMENT OF VIRAL DISEASES [patent_app_type] => utility [patent_app_number] => 17/999870 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17005258 [patent_doc_number] => 20210236419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => STEROIDAL COMPOSITIONS AND METHOD OF MAKING AND USE [patent_app_type] => utility [patent_app_number] => 17/234619 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18348899 [patent_doc_number] => 20230137010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => LONG-ACTING APOMORPHINE FORMULATIONS AND INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME [patent_app_type] => utility [patent_app_number] => 17/995888 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -227 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18737882 [patent_doc_number] => 20230346783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY [patent_app_type] => utility [patent_app_number] => 17/914587 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17895499 [patent_doc_number] => 20220305161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => MICROBIOLOGICAL TRANSPORT MEDIUM AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/213030 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18363284 [patent_doc_number] => 20230144875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID FOR TREATMENT OF CORONAVIRUSES AND SPECIFICALLY NOVEL CORONAVIRUS-19 (COVID-19) [patent_app_type] => utility [patent_app_number] => 17/906870 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17342004 [patent_doc_number] => 20220008335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => IMPLANTS AND CONSTRUCTS INCLUDING HOLLOW FIBERS [patent_app_type] => utility [patent_app_number] => 17/205444 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18310457 [patent_doc_number] => 20230114357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => CONTINUOUS MELT-COATING OF ACTIVE PHARMACEUTICAL INGREDIENTS USING SURFACTANTS FOR DISSOLUTION ENHANCEMENT [patent_app_type] => utility [patent_app_number] => 17/906514 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12300 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18091315 [patent_doc_number] => 20220409656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => SODIUM PERCARBONATE DISSOLVING BATH PRODUCT FORMULATION [patent_app_type] => utility [patent_app_number] => 17/595640 [patent_app_country] => US [patent_app_date] => 2021-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5162 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17272802 [patent_doc_number] => 20210379000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => INJECTABLE MELPHALAN COMPOSITIONS COMPRISING A CYCLODEXTRIN DERIVATIVE AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/194980 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20437 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16913889 [patent_doc_number] => 20210186981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT [patent_app_type] => utility [patent_app_number] => 17/194114 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11894 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19372980 [patent_doc_number] => 12064519 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-08-20 [patent_title] => Vaporization tablet [patent_app_type] => utility [patent_app_number] => 17/190948 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 5 [patent_no_of_words] => 3310 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16913899 [patent_doc_number] => 20210186991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS [patent_app_type] => utility [patent_app_number] => 17/189551 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17080569 [patent_doc_number] => 20210275575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => COMPOSITION FOR IMPROVING RENAL FUNCTION IN RENAL DISEASES CONTAINING MOLECULAR HYDROGEN [patent_app_type] => utility [patent_app_number] => 17/188617 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188617 [rel_patent_id] =>[rel_patent_doc_number] =>)